SHP389 is an allosteric SHP2 inhibitor, with an IC 50 of 36 nM for both SHP2 and p-ERK.

SHP389 modulates MAPK signaling in vivo[1].

2235394-90-6

C23H29ClN8O2

484.98

SHP389;SHP389

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years